tirzepatide injection area How to Inject Your Semaglutide/Tirzepatide (GLP-1 Analogs) Tirzepatide-Induced Injection Site Reaction |

If prescribed, compounded tirzepatide may be supplied in sterile vials for subcutaneous self-injection

The US Food and Drug Administration approved this first-in-class medication for the management of type 2 diabetes (T2D) in 2022 [2], for the reduction of excess weight in adults with obesity or overweight in 2023 [3], and for moderate-to-severe obstructive sleep apnea (OSA) in people with obesity in 2024 [4]

This may include personalized formulations or dosage strengths not available in commercially manufactured medications

Because Zepbound vials contain the same tirzepatide formulation as the pens, the mechanism of action is identical